Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment

While target therapies directed toward genetic mutations that drive a tumour's growth have significantly improved the outlook for many patients, they have not been as successful in controlling brain metastases in several types of cancer. In the case of...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qcRFyT
via IFTTT